Skip to search formSkip to main contentSkip to account menu

EMD640744

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Cancer Vaccines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
First-in-human trial focusing on the immunologic effects of the survivin-derived multiepitope vaccine EMD640744.
2515 Background: Survivin is a promising antigen for cancer immunotherapy based on two major criteria: tumor cells depend on its… 
2011
2011
Abstract 5516: Therapeutic vaccination with the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Background: Survivin is a promising tumor-associated… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)